These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection. Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097 [TBL] [Abstract][Full Text] [Related]
3. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection. Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717 [TBL] [Abstract][Full Text] [Related]
4. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786 [TBL] [Abstract][Full Text] [Related]
5. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells. Elias AK; Scanlon D; Musgrave IF; Carver JA Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476 [TBL] [Abstract][Full Text] [Related]
6. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482 [TBL] [Abstract][Full Text] [Related]
7. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity. Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153 [TBL] [Abstract][Full Text] [Related]
8. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198 [TBL] [Abstract][Full Text] [Related]
9. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide. Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963 [TBL] [Abstract][Full Text] [Related]
10. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen. Easterhoff D; Ontiveros F; Brooks LR; Kim Y; Ross B; Silva JN; Olsen JS; Feng C; Hardy DJ; Dunman PM; Dewhurst S Antimicrob Agents Chemother; 2013 Jun; 57(6):2443-50. PubMed ID: 23507280 [TBL] [Abstract][Full Text] [Related]
11. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI). Elias AK; Wilson MR; Carver JA; Musgrave IF Cells; 2022 Oct; 11(20):. PubMed ID: 36291126 [TBL] [Abstract][Full Text] [Related]
12. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection. Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369 [TBL] [Abstract][Full Text] [Related]
13. Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion. Brender JR; Hartman K; Gottler LM; Cavitt ME; Youngstrom DW; Ramamoorthy A Biophys J; 2009 Nov; 97(9):2474-83. PubMed ID: 19883590 [TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor. Zhang X; Chen J; Yu F; Wang C; Ren R; Wang Q; Tan S; Jiang S; Liu S; Li L Front Microbiol; 2018; 9():1330. PubMed ID: 29971062 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles. Sheik DA; Brooks L; Frantzen K; Dewhurst S; Yang J ACS Nano; 2015 Feb; 9(2):1829-1836. PubMed ID: 25619867 [TBL] [Abstract][Full Text] [Related]
16. A novel modified peptide derived from membrane-proximal external region of human immunodeficiency virus type 1 envelope significantly enhances retrovirus infection. Zhang L; Jiang C; Zhang H; Gong X; Yang L; Miao L; Shi Y; Zhang Y; Kong W; Zhang C; Shan Y J Pept Sci; 2014 Jan; 20(1):46-54. PubMed ID: 24254845 [TBL] [Abstract][Full Text] [Related]
17. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection]. Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062 [TBL] [Abstract][Full Text] [Related]
18. Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection. LoRicco JG; Xu CS; Neidleman J; Bergkvist M; Greene WC; Roan NR; Makhatadze GI J Biol Chem; 2016 Jul; 291(27):14045-14055. PubMed ID: 27226574 [TBL] [Abstract][Full Text] [Related]
19. K114 (trans, trans)-bromo-2,5-bis(4-hydroxystyryl)benzene is an efficient detector of cationic amyloid fibrils. Selmani V; Robbins KJ; Ivancic VA; Lazo ND Protein Sci; 2015 Mar; 24(3):420-5. PubMed ID: 25524064 [TBL] [Abstract][Full Text] [Related]
20. Semen-derived amyloidogenic peptides-Key players of HIV infection. Lee YH; Ramamoorthy A Protein Sci; 2018 Jul; 27(7):1151-1165. PubMed ID: 29493036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]